This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Axial: The Strategic Backbone for Bold Ambition 2030 An overview of the Axial program At the heart of AstraZeneca’s Bold Ambition 2030 lies “Axial”, an ambitious initiative to modernize its operations and propel the pharmaceutical giant toward industry leadership.
It is also important to understand the critical role of data in driving advancements in AI technologies. While technology innovations like AI evolve and become compelling across industries, effective datagovernance remains foundational for the successful deployment and integration into operational frameworks.
From finance to manufacturing to pharmaceuticals to retail, every industry is jumping on the AI/ML bandwagon. Artificial Intelligence (AI), Machine Learning (ML) and Large Language Models (LLM) have turned the world on its head. And for good reason. AI/ML has the ability to improve efficiency, drive automation, and shorten delivery cycles.
The example of the myriad of COVID-19 challenges shows that coordinated, data-driven action across boundaries has helped fast-track solutions such as testing, vaccines, and non-pharmaceutical interventions. In this article, we will explore how organizations can […].
Unlike pharmaceutical trials, medical device trials involve complex interactions between hardware, software, and human factors. This complexity is compounded by the high stakes associated with ensuring patient safety, making […] The post DataManagement for Medical Device Clinical Trials: A Guide appeared first on DATAVERSITY.
flexible grippers and tactile arrays that can improve handling of varied objects); substantial investments in datamanagement and governance; the development of new types of hardware (e.g., Access to medication (Europe, where I live, is highly dependent on pharmaceutical production abroad).
We organize all of the trending information in your field so you don't have to. Join 57,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content